Examination of autoreactive T cell clones isolated from prediabetic subjects, and patients with a recent onset of type 1 diabetes (T1D), revealed that treatment of these cells with several distinct proteases (e.g., trypsin, papain, chymotrypsin, or bromelain) decreased expression of CD3 and CD44. Here, CD44 is linked to type 1 diabetes mellitus.